Episode 3: Facioscapulohumeral muscular dystrophy, Duchenne, and the Sarepta-FDA shakeup
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Episode 3: Facioscapulohumeral muscular dystrophy, Duchenne, and the Sarepta-FDA shakeup
-
Narrated by:
-
By:
About this listen
In our neuromuscular episode, Sam and Ali interview Kristin Zwickau about the challenges facing pediatric patients with facioscapulohumeral muscular dystrophy and other rare diseases when it comes to drug development. Ali discusses the historical contributions of Charles Bell, William Gowers, and Guillaume Duchenne. Sam closes with a rundown on recent news surrounding Sarepta Therapeutics and the FDA.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.